Skip to main content

Treace Medical Concepts, Inc. (TMCI) Stock

Treace Medical Concepts, Inc. Stock Details, Movements and Public Alerts

Stock Details

Treace Medical Concepts, Inc. (TMCI), a prominent company in the healthcare sector within the medical devices industry, is based in United States and primarily trades on the NMS.Currently, the stock is trading at $4.76. Over the past 52 weeks, it has ranged between $1.17 and $7.78. This places the current price at 61.2% of its 52-week high and 306.8% above its 52-week low. Recent trading volume was recorded at 6,187. The 14-day Relative Strength Index (RSI) stands at 59.86, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $4.14 by 14.98%. Similarly, it is above its 200-day moving average of $3.00 by 58.67%. The MACD histogram is 0.03, indicating bullish momentum (MACD Line: 0.15, Signal Line: 0.12).

52-Week Range

$7.78 - $1.17

-38.82% from high · +306.84% from low

Avg Daily Volume

414,348

20-day average

100-day avg: 747,779

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

-5.60

Price to Book

4.00

EV/EBITDA

-7.19

EPS (TTM)

-$0.92

Price to Sales

1.50

Q:How is TMCI valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is TMCI's risk profile compared to the market?
Risk profile data is not available for this stock.

Performance & Growth

Profit Margin

-28.99%

Operating Margin

-32.97%

EBITDA

$-46,350,000

Return on Equity

-71.99%

Return on Assets

-17.33%

Revenue Growth (YoY)

-4.20%

Q:How profitable and efficient is TMCI's business model?
Treace Medical Concepts, Inc. achieves a profit margin of -28.99%, meaning it retains $-28.99 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of -32.97% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -71.99% and ROA at -17.33%, the company achieves moderate returns on invested capital.
Q:What are TMCI's recent growth trends?
Treace Medical Concepts, Inc.'s revenue declined by 4.20% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions. These growth metrics should be evaluated against Medical Devices industry averages for proper context.

Company Size & Market

Market Cap

$308.8M

Revenue (TTM)

$205.31M

Revenue/Share (TTM)

$3.20

Shares Outstanding

64.87M

Book Value/Share

$1.19

Asset Type

EQUITY

Q:What is TMCI's market capitalization and position?
Treace Medical Concepts, Inc. has a market capitalization of $308.8M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 64.87M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Medical Devices industry, it competes with other firms in this sector.
Q:How does TMCI's price compare to its book value?
Treace Medical Concepts, Inc.'s book value per share is $1.19, while the current stock price is $4.76, resulting in a price-to-book (P/B) ratio of 4.00. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As EQUITY, this represents a specific type of security.

Analyst Ratings

Analyst Target Price

$4.67

1.96% downside potential

Analyst Recommendations

Strong Buy

0

Buy

1

Hold

3

Sell

0

Strong Sell

1

Q:How reliable are analyst predictions for TMCI?
5 analysts cover TMCI with 20% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The bearish sentiment could create opportunity if analysts are wrong. The consensus target of $4.67 implies -2.0% downside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on TMCI?
Current analyst recommendations:01 Buy, 3 Hold, 01 Strong Sell. The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Aug 9, 2026, 02:32 AM

Technical Indicators

RSI (14-day)

59.86

Neutral

50-Day Moving Average

$4.14

14.98% above MA-50

200-Day Moving Average

$3.00

58.67% above MA-200

MACD Line

0.15

MACD Signal

0.12

MACD Histogram

0.03

Bullish

Q:What does TMCI's RSI value tell investors?
The RSI (Relative Strength Index) for TMCI is currently 59.86, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
Q:How should traders interpret TMCI's MACD and moving average crossovers?
MACD analysis shows the MACD line at 0.15 above the signal line at 0.12, with histogram at 0.03. This bullish crossover suggests upward momentum is building. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($4.14) is above the 200-day MA ($3.00), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently above both MAs, confirming strength.

Indicators last updated: Aug 8, 2026, 12:37 AM

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for TMCI and get notified when the price changes.

Stay Ahead of the Market with Treace Medical Concepts, Inc. Alerts

Set up price alerts for Treace Medical Concepts, Inc. and get notified instantly when the price hits your target. Never miss an important price movement again.